日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Validation of a novel cognitive-functional outcome measure optimized for early Alzheimer's Disease: Evidence from the VIVA-MIND trial

验证一种针对早期阿尔茨海默病优化的新型认知功能结局指标:来自 VIVA-MIND 试验的证据

Duehring, Jasmin A; Jacobs, Diane M; Salmon, David P; MacKelfresh, Andrew J; Revta, Carolyn; Meyer, Antje; Schaeffer, Michael; Schell-Mader, Sylvia; Wassmann, Tanja; Wenzkowski, Christine; Feldman, Howard H; Edland, Steven D

Calendar age and puberty-related development of regional gray matter volume and white matter tracts during adolescence

青春期区域灰质体积和白质束随日历年龄和青春期发育的变化

Ando, Ayaka; Parzer, Peter; Kaess, Michael; Schell, Susanne; Henze, Romy; Delorme, Stefan; Stieltjes, Bram; Resch, Franz; Brunner, Romuald; Koenig, Julian

BRAF Targeting Sensitizes Resistant Melanoma to Cytotoxic T Cells

BRAF 靶向治疗可增强耐药性黑色素瘤对细胞毒性 T 细胞的敏感性

Cigdem Atay #, Taekyoung Kwak #, Sergio Lavilla-Alonso, Laxminarasimha Donthireddy, Allison Richards, Valerie Moberg, Shari Pilon-Thomas, Michael Schell, Jane L Messina, Vito W Rebecca, Min Xiao, Jiufeng Tan, Gao Zhang, Jeffrey S Weber, Meenhard Herlyn, Amod A Sarnaik, Dmitry I Gabrilovich

Bone marrow CD8 T cells express high frequency of PD-1 and exhibit reduced anti-leukemia response in newly diagnosed AML patients

新诊断的急性髓系白血病(AML)患者骨髓中的CD8 T细胞高表达PD-1,且抗白血病反应降低。

Jia, Bei; Wang, Liru; Claxton, David F; Ehmann, W Christopher; Rybka, Witold B; Mineishi, Shin; Rizvi, Syed; Shike, Hiroko; Bayerl, Michael; Schell, Todd D; Hohl, Raymond J; Zheng, Hong

The tumour suppressor CYLD regulates the p53 DNA damage response

肿瘤抑制因子 CYLD 调节 p53 DNA 损伤反应

Vanesa Fernández-Majada, Patrick-Simon Welz, Maria A Ermolaeva, Michael Schell, Alexander Adam, Felix Dietlein, David Komander, Reinhard Büttner, Roman K Thomas, Björn Schumacher, Manolis Pasparakis

Exosomal microRNA miR-92a concentration in serum reflects human brown fat activity

血清中外泌体microRNA miR-92a 浓度反映人类棕色脂肪活性

Yong Chen, Joschka J Buyel, Mark J W Hanssen, Franziska Siegel, Ruping Pan, Jennifer Naumann, Michael Schell, Anouk van der Lans, Christian Schlein, Holger Froehlich, Joerg Heeren, Kirsi A Virtanen, Wouter van Marken Lichtenbelt, Alexander Pfeifer

Phase I/II Study of Metastatic Melanoma Patients Treated with Nivolumab Who Had Progressed after Ipilimumab

接受 Nivolumab 治疗且在接受 Ipilimumab 治疗后出现进展的转移性黑色素瘤患者的 I/II 期研究

Jeffrey Weber, Geoffrey Gibney, Ragini Kudchadkar, Bin Yu, Pingyan Cheng, Alberto J Martinez, Jodie Kroeger, Allison Richards, Lori McCormick, Valerie Moberg, Heather Cronin, Xiuhua Zhao, Michael Schell, Yian Ann Chen

β-arrestin-1 mediates nicotine-induced metastasis through E2F1 target genes that modulate epithelial-mesenchymal transition

β-arrestin-1 通过调节上皮-间质转化的 E2F1 靶基因介导尼古丁诱导的转移

Smitha Pillai, Jose Trevino, Bhupendra Rawal, Sandeep Singh, Michelle Kovacs, Xueli Li, Michael Schell, Eric Haura, Gerold Bepler, Srikumar Chellappan

Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms

EGFR 相互作用组突变的扰动可识别脆弱性和抗性机制

Jiannong Li, Keiryn Bennett, Alexey Stukalov, Bin Fang, Guolin Zhang, Takeshi Yoshida, Isamu Okamoto, Jae-Young Kim, Lanxi Song, Yun Bai, Xiaoning Qian, Bhupendra Rawal, Michael Schell, Florian Grebien, Georg Winter, Uwe Rix, Steven Eschrich, Jacques Colinge, John Koomen, Giulio Superti-Furga, Eric

Ubiquitin C-terminal hydrolase-L1 potentiates cancer chemosensitivity by stabilizing NOXA

泛素 C 端水解酶-L1 通过稳定 NOXA 增强癌症化学敏感性

Kerstin Brinkmann, Paola Zigrino, Axel Witt, Michael Schell, Leena Ackermann, Pia Broxtermann, Stephan Schüll, Maria Andree, Oliver Coutelle, Benjamin Yazdanpanah, Jens Michael Seeger, Daniela Klubertz, Uta Drebber, Ulrich T Hacker, Martin Krönke, Cornelia Mauch, Thorsten Hoppe, Hamid Kashkar